Patents by Inventor Erica Teixeira Prates

Erica Teixeira Prates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11781107
    Abstract: Disclosed herein are the genetically modified Pseudomonas with improved tolerance to hydroxycinnamic acids.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: October 10, 2023
    Assignees: Alliance for Sustainable Energy, LLC, UT-Battelle, LLC
    Inventors: Gregg Tyler Beckham, Christopher W. Johnson, Allison Jean Zimont Werner, Davinia SalvachĂșa RodrĂ­guez, Daniel A. Jacobson, Erica Teixeira Prates, Elsayed Tharwat Tolba Mohamed, Adam Michael Feist
  • Publication number: 20220101945
    Abstract: The present disclosure is directed to methods of identifying structural variants (SVs) from single nucleotide polymorphisms (SNPs) that demonstrate non-Mendelian inheritance pattern (NMI) and finding the biological relevance of the SVs through machine learning. Also disclosed are processors programmed to identify biologically-relevant SVs and computer-readable storage devices comprising instructions to identify biologically-relevant SVs.
    Type: Application
    Filed: September 28, 2021
    Publication date: March 31, 2022
    Inventors: Michael R. Garvin, Daniel A. Jacobson, David Kainer, Erica Teixeira Prates
  • Publication number: 20220008380
    Abstract: This disclosure provides methods for treating a SARS-CoV-2 infection in a subject comprising administering to the subject an effective amount of an inhibitor of COVID-induced RAS imbalance, that downregulates, for example, the Bradykinin system, the Renin-Angiotensin system, the hyaluronan synthesis pathway, or the fibrinogenesis pathway.
    Type: Application
    Filed: July 7, 2021
    Publication date: January 13, 2022
    Inventors: Daniel A. Jacobson, Erica Teixeira Prates, John I. Miller, Michael R. Garvin